Atai: Following the path that Spravato laid and moving beyond it
Investing Experts
00:00
Innovating Psychedelic Therapies for Mental Health
This chapter explores a biotech company's innovative approaches to developing psychedelic therapies for treatment-resistant depression. It highlights the mission to enhance patient experience and reduce treatment frequency, while also examining the market potential following the success of existing treatments like Spravato.
Transcript
Play full episode
